Literature DB >> 9400938

Germline BRCA2 mutations in men with breast cancer.

E Mavraki1, I C Gray, D T Bishop, N K Spurr.   

Abstract

Breast cancer in men is rare and is clearly due in some cases to an inherited predisposition. A total of 28 male breast cancer patients were tested for BRCA2 mutations; two frameshifts and one putative missense mutation were identified. One of the frameshifts was detected in the same position as a mutation estimated to be responsible for 40% of all male breast cancer cases in Iceland.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9400938      PMCID: PMC2228180          DOI: 10.1038/bjc.1997.574

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  26 in total

1.  Sensitivity of single-strand conformation polymorphism and heteroduplex method for mutation detection in the cystic fibrosis gene.

Authors:  M Ravnik-Glavac; D Glavac; M Dean
Journal:  Hum Mol Genet       Date:  1994-05       Impact factor: 6.150

2.  Identification of the breast cancer susceptibility gene BRCA2.

Authors:  R Wooster; G Bignell; J Lancaster; S Swift; S Seal; J Mangion; N Collins; S Gregory; C Gumbs; G Micklem
Journal:  Nature       Date:  1995 Dec 21-28       Impact factor: 49.962

3.  The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions.

Authors:  V C Sheffield; J S Beck; A E Kwitek; D W Sandstrom; E M Stone
Journal:  Genomics       Date:  1993-05       Impact factor: 5.736

4.  Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.

Authors:  R Wooster; S L Neuhausen; J Mangion; Y Quirk; D Ford; N Collins; K Nguyen; S Seal; T Tran; D Averill
Journal:  Science       Date:  1994-09-30       Impact factor: 47.728

5.  Cloning, chromosomal mapping and expression pattern of the mouse Brca2 gene.

Authors:  F Connor; A Smith; R Wooster; M Stratton; A Dixon; E Campbell; T M Tait; T Freeman; A Ashworth
Journal:  Hum Mol Genet       Date:  1997-02       Impact factor: 6.150

6.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

Authors:  Y Miki; J Swensen; D Shattuck-Eidens; P A Futreal; K Harshman; S Tavtigian; Q Liu; C Cochran; L M Bennett; W Ding
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

7.  The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals.

Authors:  J P Struewing; D Abeliovich; T Peretz; N Avishai; M M Kaback; F S Collins; L C Brody
Journal:  Nat Genet       Date:  1995-10       Impact factor: 38.330

8.  Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer.

Authors:  J P Struewing; L C Brody; M R Erdos; R G Kase; T R Giambarresi; S A Smith; F S Collins; M A Tucker
Journal:  Am J Hum Genet       Date:  1995-07       Impact factor: 11.025

9.  Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q.

Authors:  M R Stratton; D Ford; S Neuhasen; S Seal; R Wooster; L S Friedman; M C King; V Egilsson; P Devilee; R McManus
Journal:  Nat Genet       Date:  1994-05       Impact factor: 38.330

10.  Genetic analysis of breast cancer in the cancer and steroid hormone study.

Authors:  E B Claus; N Risch; W D Thompson
Journal:  Am J Hum Genet       Date:  1991-02       Impact factor: 11.025

View more
  12 in total

1.  Founder BRCA1/2 mutations among male patients with breast cancer in Israel.

Authors:  J P Struewing; Z M Coriaty; E Ron; A Livoff; M Konichezky; P Cohen; M B Resnick; B Lifzchiz-Mercerl; S Lew; J Iscovich
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

2.  Mutations in BRCA2 and PALB2 in male breast cancer cases from the United States.

Authors:  Yuan Chun Ding; Linda Steele; Chih-Jen Kuan; Scott Greilac; Susan L Neuhausen
Journal:  Breast Cancer Res Treat       Date:  2010-10-07       Impact factor: 4.872

3.  High detection rate for BRCA2 mutations in male breast cancer families from North West England.

Authors:  D G Evans; M Bulman; K Young; D Gokhale; F Lalloo
Journal:  Fam Cancer       Date:  2001       Impact factor: 2.375

4.  BRCA1/2 mutation analysis in male breast cancer families from North West England.

Authors:  D G R Evans; Mike Bulman; Karen Young; Emma Howard; Stuart Bayliss; Andrew Wallace; Fiona Lalloo
Journal:  Fam Cancer       Date:  2007-07-17       Impact factor: 2.375

Review 5.  The genetic epidemiology of breast cancer genes.

Authors:  Deborah Thompson; Douglas Easton
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-07       Impact factor: 2.673

6.  Variation in cancer risks, by mutation position, in BRCA2 mutation carriers.

Authors:  D Thompson; D Easton
Journal:  Am J Hum Genet       Date:  2001-01-19       Impact factor: 11.025

Review 7.  Carcinoma of the male breast.

Authors:  J F De los Santos; T A Buchholz
Journal:  Curr Treat Options Oncol       Date:  2000-08

8.  BRCA2 mutations in 154 finnish male breast cancer patients.

Authors:  Kirsi Syrjäkoski; Tuula Kuukasjärvi; Kati Waltering; Karin Haraldsson; Anssi Auvinen; Ake Borg; Tommi Kainu; Olli-P Kallioniemi; Pasi A Koivisto
Journal:  Neoplasia       Date:  2004 Sep-Oct       Impact factor: 5.715

9.  Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: the Korean Hereditary Breast Cancer (KOHBRA) Study.

Authors:  Byung Ho Son; Sei Hyun Ahn; Sung-Won Kim; Eunyoung Kang; Sue K Park; Min Hyuk Lee; Woo-Chul Noh; Lee Su Kim; Yongsik Jung; Ku Sang Kim; Dong-Young Noh; Byung-In Moon; Young Jin Suh; Jeong Eon Lee; Doo Ho Choi; Sung Yong Kim; Sung Hoo Jung; Cha Kyong Yom; Hyde Lee; Jung-Hyun Yang
Journal:  Breast Cancer Res Treat       Date:  2012-03-02       Impact factor: 4.872

10.  BRCA1 and BRCA2 mutations in a population-based study of male breast cancer.

Authors:  Victoria M Basham; Julian M Lipscombe; Joanna M Ward; Simon A Gayther; Bruce A J Ponder; Douglas F Easton; Paul D P Pharoah
Journal:  Breast Cancer Res       Date:  2001-11-21       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.